Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific CD16-binding molecules and their use in the treatment of disease

Bispecific CD16-binding molecules and their use in the treatment of disease

US Patent 11795226 · Granted Oct 24, 2023

Estimated economic value: $6,163,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD137 binding molecules and uses thereof2025
N-containing heteroaryl derivative and pharmaceutical composition comprising sam2025
Methods of generating highly-crystalline recombinant spider silk protein fibers2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
CD3-binding molecules capable of binding to human and non-human CD32024
HER2/neu-specific antibodies and methods of using same2024
Pyrazole compounds, pharmaceutical compositions thereof and use thereof2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Composite material, and methods for production thereof2024